Protalix BioTherapeutics Price Chart
Protalix BioTherapeutics Volume Chart
Protalix BioTherapeutics Market Segments
Premarket
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $2.12 |
|---|---|
| Close | $2.12 |
| Low | $2.12 |
| Low Change | 0.00 (0.00%) |
| High | $2.12 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 2.658K |
| Dollar Volume | $5.63K |
Regular Trading Hours Yesterday
-0.03(-1.40%)
| Open | $2.15 |
|---|---|
| Close | $2.12 |
| Low | $2.12 |
| Low Change | -0.03 (-1.40%) |
| High | $2.16 |
| High Change | +0.01 (+0.45%) |
| Range | $0.04 |
| Volume | 314.138K |
| Dollar Volume | $665.97K |
Premarket Yesterday
*No Trades in Segment
Protalix BioTherapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $2.16 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.23 |
| 20 Day Moving Average (SMA20) | $2.23 |
| 50 Day Moving Average (SMA50) | $2.50 |
| 100 Day Moving Average (SMA100) | $2.29 |
| 200 Day Moving Average (SMA200) | $2.07 |
Protalix BioTherapeutics Statistics
| Average Volume (30 Days) | 866.93K |
|---|---|
| P/E Ratio (Current) | -27.00 |
| EPS (Current) | -$0.08 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$13.63M |
| Cash Ratio | 0.55 |
| Current Ratio | 2.49 |
| Quick Ratio | 1.52 |
| Debt to Equity | 0.00 |
| Enterprise Value | $159.35M |
| EV to EBITDA | -39.49 |
| EV to Sales | 3.02 |
| Price to Book | 3.61 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 3.30 |
| Return on Assets | -0.08% |
| Return on Equity | -0.14% |
Protalix BioTherapeutics Stock Splits
There has been 1 stock split for Protalix BioTherapeutics (PLX). The reverse stock split occured on December 20, 2019 and reduced the outstanding shares at a ratio of 10:1.
| Date | Type | Ratio |
|---|---|---|
| Dec 20, 2019 | Reverse | 10:1 |
Protalix BioTherapeutics Dividends
There have been no dividends for Protalix BioTherapeutics (PLX).